Alnylam Pharmaceuticals
Ken Howerton is a seasoned professional with extensive experience in quality operations within the pharmaceutical and biotechnology industries. Currently serving as Vice President of Quality Operations at Alnylam Pharmaceuticals since January 2018, Ken oversees all GMP operations supporting both clinical and commercial supply. Prior roles include Senior Director of Site Quality at Shire, where Ken managed quality for a $2 billion greenfield project and achieved FDA approval without critical observations, and Director of Operations QA at Baxter International, where Ken led compliance standards for a plasma fractionation facility. Additional experience includes significant roles at Pfizer, Bausch + Lomb, and Abbott, where Ken focused on compliance, validation, and quality assurance across various products and processes. Ken holds a B.S. in Microbiology from the University of Illinois Urbana-Champaign, earned in 1988.
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.